Measurement error in continuous endpoints in randomised trials: Problems and solutions

por Nab, L., Groenwold, R.H.H., Welsing, P.M.J., van Smeden, M.
Publicado 2019

Toll-like receptor 4 polymorphism influences susceptibility to but not severity and outcome of rheumatoid arthritis

por Radstake, TRDJ, Franke, B, Hanssen, S, Welsing, P, Joosten, LAB, van Riel, PLCM, Barrera, P, van den Berg, WB
Publicado 2004

Calibration of FRAX ® 3.1 to the Dutch population with data on the epidemiology of hip fractures

por Lalmohamed, A., Welsing, P. M. J., Lems, W. F., Jacobs, J. W. G., Kanis, J. A., Johansson, H., De Boer, A., De Vries, F.
Publicado 2011

Local and systemic inflammatory lipid profiling in a rat model of osteoarthritis with metabolic dysregulation

por de Visser, H. M., Mastbergen, S. C., Ravipati, S., Welsing, P. M. J., Pinto, F. C., Lafeber, F. P. J. G., Chapman, V., Barrett, D. A., Weinans, H.
Publicado 2018

Effectiveness of Remission Induction Strategies for Early Rheumatoid Arthritis: a Systematic Literature Review

por Verhoeven, M. M. A., Welsing, P. M. J., Bijlsma, J. W. J., van Laar, J. M., Lafeber, F. P. J. G., Tekstra, J., Jacobs, J. W. G.
Publicado 2019

Knee Joint Distraction Compared to Total Knee Arthroplasty for Treatment of End Stage Osteoarthritis: Simulating Long-Term Outcomes and Cost-Effectiveness

por van der Woude, J. A. D., Nair, S. C., Custers, R. J. H., van Laar, J. M., Kuchuck, N. O., Lafeber, F. P. J. G., Welsing, P. M. J.
Publicado 2016

Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000–2010

por Klop, C., Gibson-Smith, D., Elders, P. J. M., Welsing, P. M. J., Leufkens, H. G. M., Harvey, N. C., Bijlsma, J. W. J., van Staa, T.-P., de Vries, F.
Publicado 2015

Are changes in bone mineral density different between groups of early rheumatoid arthritis patients treated according to a tight control strategy with or without prednisone if oste...

por van der Goes, M. C., Jacobs, J. W. G., Jurgens, M. S., Bakker, M. F., van der Veen, M. J., van der Werf, J. H., Welsing, P. M. J., Bijlsma, J. W. J.
Publicado 2012

Can optical spectral transmission assess ultrasound-detected synovitis in hand osteoarthritis?

por Besselink, N. J., Jacobs, J. W. G., Westgeest, A. A. A., van der Meijde, P., Welsing, P. M. J., Marijnissen, A. C. A., Lafeber, F. P. J. G., Van Spil, W. E.
Publicado 2019

The multi-biomarker disease activity test for assessing response to treatment strategies using methotrexate with or without prednisone in the CAMERA-II trial

por Jurgens, M. S., Safy-Khan, M., de Hair, M. J. H., Bijlsma, J. W. J., Welsing, P. M. J., Tekstra, J., Lafeber, F. P. J. G., Sasso, E. H., Jacobs, J. W. G.
Publicado 2020

P1566: PROTON PUMP INHIBITION FOR SECONDARY HEMOCHROMATOSIS IN HEREDITARY ANEMIA, A PHASE III PLACEBO-CONTROLLED RANDOMIZED CROSS-OVER CLINICAL TRIAL

por Van Vuren, A., Kerkhoffs, J., Schols, S., Rijneveld, A., Nur, E., Peereboom, D., Gandon, Y., Welsing, P., van Wijk, R., Schutgens, R., van Solinge, W., Marx, J., Leiner, T., Biemond, B., van Beers, E.
Publicado 2022

A Personalized Approach to Biological Therapy Using Prediction of Clinical Response Based on MRP8/14 Serum Complex Levels in Rheumatoid Arthritis Patients

por Nair, S. C., Welsing, P. M. J., Choi, I. Y. K., Roth, J., Holzinger, D., Bijlsma, J. W. J., van Laar, J. M., Gerlag, D. M., Lafeber, F. P. J. G., Tak, P. P.
Publicado 2016

Long-term persistence with anti-osteoporosis drugs after fracture

por Klop, C., Welsing, P. M. J., Elders, P. J. M., Overbeek, J. A., Souverein, P. C., Burden, A. M., van Onzenoort, H. A. W., Leufkens, H. G. M., Bijlsma, J. W. J., de Vries, F.
Publicado 2015